Whether strawberry supplementation mitigates the risk for late-life dementia.
Kodiak ‘reboots’ Eylea competitor after positive data in diabetic vision loss trial
Despite two failed late-stage trials, Palo Alto-based biotech Kodiak Sciences said it’s going to restart development of its potential Eylea rival after it met all